Third, IL-6 impacts the anti-tumor immune response in HNSCC [15]; it regulates the recruitment of immune cells like myeloid-derived suppressor cells and regulatory T cells, which suppress effector immune cells, such as cytotoxic T cells and NK cells, leading to immune evasion by the tumor [16]. Here, IL6 is linked to head and neck squamous cell carcinoma.